Results 191 to 200 of about 2,408,361 (302)
Scaling genomic reanalysis to unlock diagnoses and transform rare disease care. [PDF]
Rockowitz S +47 more
europepmc +1 more source
Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders
ABSTRACT Narcolepsy type 1 (NT1) is caused by the loss of hypocretin‐1 leading to excessive daytime sleepiness and cataplexy. Additionally, disrupted nighttime sleep has become an increasingly recognized feature of NT1. As the glymphatic fluid movement has been linked to sleep architecture, we investigated cerebrospinal fluid (CSF) Aquaporin‐4 (AQP4 ...
Jonas Ranke +5 more
wiley +1 more source
Rare disease mimicking multisystem inflammatory syndrome in children. [PDF]
Akar A.
europepmc +1 more source
TrialR: critical enablers and the need for reusable Rare Disease Clinical Trial infrastructure in Western Australia. [PDF]
MacDonald B +5 more
europepmc +1 more source
Case Report of Andersen-Tawil Syndrome: Rare Presentation of a Rare Disease. [PDF]
Shakya H +4 more
europepmc +1 more source
A Case of Cerebral Cortical Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.
Sixiao Liu, Kunqian Ji, Wei Wu, Wei Li
wiley +1 more source
Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez +10 more
wiley +1 more source
KLINSE: a comprehensive service model for rare disease information and care management support. [PDF]
Jäger K +5 more
europepmc +1 more source

